Optical Biometry Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Optical Biometry Devices Market Trends and Insights

Rising Cataract Surgery Volumes in Aging Populations

Cataract prevalence rises with age and continues to shape the long-term need for preoperative eye measurements. Cataract surgical coverage reached 48.2% globally in 2025 and is projected to reach 52.3% by 2030.^{[1]Ian McCormick, Yamna Ouchtar, David Macleod, et al., “Effective Cataract Surgical Coverage in Adults Aged 50 Years and Older: Empirical Estimates From Population-Based Surveys in 68 Countries and Modelled Estimates for 2000-30,” The Lancet Global Health, doi.org} The expected improvement remains below the stated decade target, which leaves a large backlog of patients needing treatment. The WHO African region recorded effective cataract surgical coverage of 23.6% in 2025, showing the scale of the access gap. The optical biometry devices market benefits when cataract programs expand because each surgery requires dependable measurements before lens selection. Suppliers with durable and portable products are better positioned where first-time equipment placement matters more than replacement demand.

Shift to Swept-Source OCT for Dense Cataracts and Complex Eyes

Swept-Source Optical Coherence Tomography uses a 1,050 nm wavelength that can obtain measurements through denser cataracts than some earlier optical methods. A 2026 prospective study reported that ARGOS with the Barrett Universal II formula placed 98% of eyes within ±0.50 D of refractive prediction error across normal and long axial lengths.^{[2]Omar Nusair, et al., “Refractive Outcomes After Cataract Surgery Using Swept-Source OCT Biometry and Image-Guided Toric IOL Alignment: A Prospective Comparative Study in Normal Versus Long Axial Length Eyes,” Scientific Reports, nature.com} This performance matters for patients with high myopia and for premium toric or multifocal lens procedures. The optical biometry devices market is gaining from this clinical use because complex cases are often treated in high-volume surgical centers. When a biometer obtains dependable readings in difficult eyes, clinics have less reason to retain immersion A-scan ultrasound as a routine fallback. That pattern can support replacement purchases where clinical teams seek one device for both standard and challenging cases.

Premium IOL Adoption Increasing Measurement Requirements

Multifocal, extended-depth-of-focus, and toric intraocular lenses require accurate keratometry and axial-length measurements. A measurement error above 0.3 D can affect refractive results and patient satisfaction in these procedures. Surgeons using premium lenses increasingly need total keratometry values that include anterior and posterior corneal information. This requirement favors platforms that combine high-quality optical acquisition with current lens calculation formulas. ZEISS presented expanded Kane formula integration for the IOLMaster 700 at ASCRS 2026.^{[3]ZEISS Medical Technology, “Noticing ZEISS AI IOL Calculator as a Formula Option in ZEISS VERACITY Surgery Planner? Here’s Why,” Carl Zeiss Meditec, zeiss.com} The optical biometry devices market can benefit as practices upgrade equipment to support premium lens consultations and the higher expectations that follow these procedures.

Integration of Biometry with Digital Cataract Planning Workflows

Connected biometry systems can transfer measurements directly into cataract planning software and reduce manual data entry. A published workflow study found that digital preparation reduced overall time from 30.58 minutes to 16.48 minutes and removed manual data transfer. The same work reported a 46% reduction in preparation time, which helps high-volume surgery centers improve process consistency. The optical biometry devices market increasingly rewards suppliers that offer planning tools, connectivity, and reliable support after installation. Digital workflows can also make it harder for clinics to change brands once patient records and operating processes are linked to a vendor system. Interoperability requirements such as DICOM and HL7 add value to vendors that can work within hospital information systems.

High Capital Cost and Budget Constraints in Emerging Markets

Capital budgets limit the adoption of advanced optical instruments in district hospitals and smaller outpatient centers. Many facilities in South Asia, Southeast Asia, and sub-Saharan Africa continue to rely on ultrasound because funding and reimbursement are limited. Without payment mechanisms for optical biometry, providers may struggle to recover the cost through procedure revenue. This can keep facilities on lower-accuracy equipment even when clinicians prefer optical measurements. Guidance for low-resource eye care settings identifies maintenance, calibration, and fallback measurement practices as important quality issues. The optical biometry devices market therefore faces a slower adoption path where equipment finance, service capacity, and reimbursement remain weak.

Shortage of Trained Ophthalmic Technicians and Biometry Operators

Advanced optical biometry needs trained staff who can obtain consistent measurements and recognize unreliable scans. Research in Southern Ethiopia found that 18.2% of sampled facilities employed dedicated eye care technical staff. Staff shortages can lead to repeat scans, inconsistent results, and poor lens power selection. These issues are more serious where premium lenses or complex cataract cases require narrow measurement tolerances. Formula updates, total keratometry functions, and connected software can create further training needs after a device is installed. The optical biometry devices market is constrained in these settings until training and clinical support are available alongside equipment purchases.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Technology: SS-OCT Leads in Complex Cases While OLCR Expands in Routine Settings

Swept-source optical coherence tomography biometers held 48.23% revenue share in 2025. They are widely used in tertiary surgical centers that need readings through dense cataracts and posterior corneal data for toric lens planning. A 2026 comparison of CASIA2 and IOLMaster 700 examined the agreement of ocular biometry and lens calculation performance in cataract patients. 

Optical low-coherence reflectometry is the fastest-growing technology category, with a projected 7.28% CAGR through 2031. Its price position and validated performance in routine cataract cases support demand among mid-volume providers, while the Topcon Aladdin platform combines OLCR biometry, corneal topography, calculation tools, and DICOM or HL7 connectivity. Within the optical biometry devices industry, the technology choice increasingly reflects patient mix, workflow needs, and capital limits rather than a single performance standard.

By Device Type: Non-Contact Systems Lead While Contact Options Serve Difficult Cases

Non-contact optical biometry devices captured 53.27% revenue share in 2025. They reduce corneal compression concerns associated with contact ultrasound and support patient-friendly testing. Automated alignment can help clinics manage high patient throughput during cataract surgery sessions. Their use in routine preoperative care supports a large installed base across the optical biometry devices market, hospitals, and ophthalmology clinics.

Contact optical biometry devices are the fastest-growing device type, with a projected 8.34% CAGR through 2031. Their demand reflects clinical conditions in which severe media opacity can limit non-contact optical readings. Hybrid systems that provide contact and non-contact options can address varied patient severity within one facility. The optical biometry devices market retains a role for contact modalities even as non-contact testing remains the preferred approach for standard cases.

By Application: Cataract Planning Remains Central While IOL Calculation Grows

Cataract surgery planning held 41.11% revenue share in 2025. It remains the main use because biometric measurements guide lens selection before cataract procedures. Accurate data has become closely linked to surgical quality and refractive expectations. A 2025 study found that changes in ocular biometry over time affected intraocular lens power calculation accuracy. That finding supports repeat measurement close to the procedure when clinical circumstances require it.

Intraocular lens power calculation is the fastest-growing application, with a forecasted CAGR of 7.63% through 2031. Artificial intelligence and machine-learning formulas depend on detailed biometric inputs and can be integrated into planning systems, while ZEISS describes its AI IOL Calculator as a formula option in the VERACITY Surgery Planner. The optical biometry devices market can therefore capture value from both procedure volume and digital planning use.

By End-User: Hospitals Hold Volume While Clinics Expand Premium Services

Hospitals held 43.56% revenue share in 2025. They treat many high-acuity cataract cases, including dense cataracts, corneal pathology, and post-refractive surgery eyes. These clinical needs support investment in high-uptime systems with service coverage. Ambulatory surgical centers often consider mid-tier systems that meet routine care requirements at lower capital cost.

Ophthalmology clinics and specialized eye care centers are expected to be the fastest-growing end-user group at a 6.92% CAGR through 2031. Private practices in Asia-Pacific are expanding premium lens consultations that can justify investment in more capable biometers and support serial axial-length monitoring for children and adolescents in myopia management programs. The optical biometry devices industry and the optical biometry devices market have a broader customer base when equipment can serve cataract workflows and ongoing monitoring needs.

Geography Analysis

North America held 48.36% of the optical biometry devices market share in 2025. The region benefits from high cataract surgery volumes, dense ophthalmology networks, premium lens use, and reimbursement support. The United States remains an important launch setting for integrated pretesting and workflow products, and Topcon Healthcare received FDA 510(k) clearance for its OMNIA 4-in-1 automated pretesting solution in November 2025. Academic medical centers and specialist practices also provide clinical evidence that supports wider adoption of high-end biometry platforms.

Europe is a significant contributor to revenue, with Germany, the United Kingdom, and France among its larger national markets. Universal health systems fund cataract procedures and commonly treat biometry as a standard preoperative step. Established reimbursement can slow upgrades when existing devices meet approved clinical protocols and reduce replacement urgency even where newer SS-OCT systems offer additional features. The optical biometry devices market faces a higher compliance burden in Europe, while established suppliers can use certified portfolios to protect access.

Asia-Pacific is projected to be the fastest-growing region, with a projected 8.4% CAGR through 2031. The optical biometry devices market in China, India, South Korea, and Japan gains support from private ophthalmology expansion, premium lens adoption, and local manufacturing. The Middle East and Africa show a sharp divide between premium demand in Gulf Cooperation Council markets and limited access in sub-Saharan Africa. South America remains a smaller growth area where import tariffs and restricted reimbursement constrain adoption, although private clinics in major cities continue to create demand.